Page last updated: 2024-11-05

thiotepa and Diabetes Insipidus, Neurogenic

thiotepa has been researched along with Diabetes Insipidus, Neurogenic in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Diabetes Insipidus, Neurogenic: A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DAVIS, PL1
SHUMWAY, MH1
SIU, B1

Other Studies

1 other study available for thiotepa and Diabetes Insipidus, Neurogenic

ArticleYear
Triethylenethiophosphoramide in treatment of metastatic cerebral malignancy.
    Journal of the American Medical Association, 1958, Jun-07, Volume: 167, Issue:6

    Topics: Antineoplastic Agents; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diagnosis, Differential;

1958
chemdatabank.com